Program Book
Total Page:16
File Type:pdf, Size:1020Kb
ND Schizophrenia 2 International Research Society Florence Conference 10-14 April, 2010 Dear Attendees, The Schizophrenia International Research Society, a non-profit organization dedicated to promoting research and communication among research scientists internationally about schizophrenia, sincerely appreciates your interest in the Society and our conference. The first congress in 2008 was a major success for the field attracting approximately 1500 attendees from 43 countries. We anticipate an even higher attendance at this congress with more of the best investigators in the field of schizophrenia in attendance. The Schizophrenia International Research Society was founded in 2005 with the goal of bringing together scientists from around the world to exchange the latest advances in biological and psychosocial research in schizophrenia. The Society strives to facilitate international collaboration to discover the causes and better treatments for schizophrenia and related spectrum disorders. Part of the mission of the Society is to promote educational programs in order to effectively disseminate new research findings and to expedite the publication of new and newsworthy research on schizophrenia. It is estimated that 1 in every 100 people in the world live with this disease. The Society and its meetings strive to increase the understanding of the personal, familial and societal impact of schizophrenia. Now more than ever there is a need for increased research funding for schizophrenia research around the world. By attending the 2nd Biennial Conference of the Society you will be exposed to sessions that will assist you to: • Foster communication and advance knowledge about the multiple treatment possibilities for schizophrenia. • Develop the best methods to design new intervention studies. • Discuss strategies for new treatment development. • Review the status of genetic findings. • Learn methods to advance genetic research in schizophrenia. • Review brain imaging data in relation to pathophysiology and disease progression. • Translate basic neuroscience findings of relevance to clinical practice, and • Understand differences in schizophrenia research and outcome of the research across diverse geographic areas and cultures. In addition to learning from the latest, cutting edge research in the field, we hope you will enjoy the beautiful city of Florence and its rich history. Please remember to complete an evaluation at the end of the conference so the Society can continue to improve its educational offerings. If you are not already a member, please stop by the registration desk and inquire about member benefits and how to join. We hope you enjoy this conference. Sincerely, The Organizers John Kane, President Lynn E. DeLisi, Secretary René S. Kahn, Treasurer Wolfgang W. Fleischhacker, Meeting Liaison Chair Eve Johnstone, 2010 Program Committee Chair Celso Arango, 2010 Program Committee Co-Chair FINAL PROGRAMME Table of Contents General Information 2 General Information Saturday, 10 April 13 Sunday, 11 April 16 Monday, 12 April 23 Tuesday, 13 April 30 Wednesday, 14 April 38 Sunday Posters 48 Monday Posters 71 Tuesday Posters 94 1 Index of Presenters and Authors 117 ND Schizophrenia 2 International Research Society Florence Conference 10-14 April, 2010 Acknowledgements The Schizophrenia International Research Society appreciates the generous support of the Society from our 2010 Supporting Corporations. General Information Platinum Silver We also recognize and appreciate the 2010 Biennial Schizophrenia International Research Conference support by way of an educational grant from: • Eli Lilly & Company • F. Hoffman - La Roche Ltd. The Junior Travel Award Fellowship Program is sponsored by an R13 grant from the U.S. National Institute of Mental Health to Harvard Medical School (LE DeLisi, PI) (Grant ID: R13MH082446). 2010 Program Committee Eve Johnstone, Program Committee Chair - UK Dieter Naber - Germany Celso Arango, Program Committee Co-chair - Spain Jim van Os - The Netherlands Elizabeth Cantor-Graae - Sweden Cyndi Shannon Weickert - Australia Eric Chen - China Martha Shenton - USA Michael Davidson – Israel Pamela Sklar - USA Sonia Dolfus - France Si Tianmei - China Robin Emsley - South Africa Dawn Velligan - USA Susan Essock - USA Antonio Vita - Italy Birte Glenthøj - Denmark Til Wykes - UK Anthony Grace - USA Shitij Kapur - UK Travel Award Selection Committee: Richard Keefe - USA Lynn E. DeLisi, Chair Don Linszen - The Netherlands Matcheri Keshavan Stephen Marder - USA Margaret Niznikiewicz John McGrath - Australia Larry Seidman Bita Moghaddam - USA Martha Shenton 2 FINAL PROGRAMME Congratulations to the following 2010 Travel Fellows. Moogeh Baharnoori Alexandre Loch Cali Bartholomeusz Mahesh Menon Rachel Batty Jessica Merchan Naranjo Aurelie Boucher Gemma Modinos General Information Lisa Buchy Nashaat Adel Mohamed Christopher Chaddock Barnaby Nelson Bongikosi Chiliza Anna-Karin Neubeck Renan Pedra De Souza Hsiao Piau Ng Melanie Focking Gabriela Novak Alexander Fornito Owolabi Oluwaseun Juan Gallego Diana Prata Darya Gaysina Anca Radulescu Hiroaki Hori Naren Rao Gisele Huf Igor Riecansky Joost Janssen Darryl Smith Renaud Jardri Renate Thienel Shambhi Dutta Joshi Hanan Trotman Shi Hyun Kang Hiroyuki Uchida James Kirkbride Kristen Woodberry Yousri Kissi Mei Hong Xiu Deepak Kumar 3 ND Schizophrenia 2 International Research Society Florence Conference 10-14 April, 2010 Schizophrenia International Research Society Officers, Board and International Advisory Committee General Information OFFICERS: Wolfgang Gaebel - Germany John Kane, President Wagner Gattaz - Brazil Lynn DeLisi, Secretary Birte Glenthøj - Denmark René Kahn, Treasurer Anthony Grace - USA Michael Green - USA BOARD OF DIRECTORS (2009 – 2010): Raquel Gur - USA William Carpenter - USA Daniel Javitt - USA Tim Crow - UK Eve Johnstone - UK Lynn E. DeLisi - USA Shitij Kapur - UK Wolfgang Fleischhacker - Austria Richard Keefe - USA Philip Harvey - USA Jun Soo Kwon - Korea René Kahn - The Netherlands Verónica Larach - Chilé John Kane - USA David Lewis - USA Robin Murray - UK Mario Maj - Italy Henry A. Nasrallah - USA Stephen Marder - USA Charles Schulz - USA Patrick McGorry - Australia John McGrath - Australia INCOMING OFFICERS: Dieter Naber - Germany Robin Murray - UK, President Christos Pantelis - Australia John Kane - USA, President-Elect Joseph Peuskens - Belgium Lynn E. DeLisi - USA, Secretary Martha Shenton - USA René Kahn - The Netherlands, Treasurer Masatoshi Takeda - Japan Nori Takei - Japan INCOMING BOARD OF DIRECTORS: Carol Tamminga - USA Jean Addington - Canada Thara Rangaswamy - India Mary Cannon - Ireland Si Tianmei - China Wolfgang Fleischhacker - Austria Jim van Os - The Netherlands Phillip Harvey - USA Antonio Vita - Italy Shitij Kapur - UK John Waddington - Ireland Stephen Marder - USA Daniel Weinberger - USA John McGrath - Australia Til Wykes - UK Alison Yung - Australia Yu Xin - China INTERNATIONAL ADVISORY COUNCIL: Jean Addington - Canada Celso Arango - Spain Francine Benes - USA David Braff - USA Eric Chen - China Michael Davidson - Israel J.F.W. Deakin - UK 4 Robin Emsley - South Africa FINAL PROGRAMME Continuing Medical Education ACCME The 2010 Schizophrenia International Research Conference is jointly sponsored by the Schizophrenia International Research Society and Vanderbilt University School of Medicine. This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing General Information Medical Education (ACCME). Vanderbilt School of Medicine is accredited by the ACCME to provide continuing medical education for physicians. Vanderbilt School of Medicine designates this educational activity for a maximum of 31.75 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity. There will be a $50.00 USD charge for scientific registrants to obtain CME credits. It is the policy of Vanderbilt School of Medicine that participants in CME activities be made aware of any affiliation or financial interest that may affect the speaker’s presentation(s). Each speaker (plenary, panel, and study group) and poster presenter has completed a conflict of interest form; the information from these forms will be available online at www.schizophreniaconference.com and on the abstract website. EACCME Credits will be offered from EACCME. For more information, please inquire at the Registration Desk. Italian Ministry of Health Credits Credits will be offered from the Italian Ministry of Health. For more information, please inquire at the Registration Desk. Learning Objectives: After participating in the 2010 Schizophrenia International Research Society attendees should be able to: • Foster communication and advance knowledge about the multiple treatment possibilities for schizophrenia. • Develop the best methods to design new intervention studies. • Discuss strategies for new treatment development. • Review the status of genetic findings. • Learn methods to advance genetic research in schizophrenia. • Review brain imaging data in relation to pathophysiology and disease progression. • Translate basic neuroscience findings of relevance to clinical practice. • Understand differences in schizophrenia research and outcome of the research across diverse geographic areas and cultures. Disclosures Disclosures for 2010 speakers, plenary, special session, symposia, oral presentations and poster presenters, may be found online at: www.schizophreniaconference.com